KpATCC43816 Protein target profile
4-hydroxy-3-methylbut-2-enyl diphosphate reductase
Accession: VK055_2551
Strong target candidate with converging metabolic, structural and chemical evidence.
Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.
Main supporting evidence
Evidence coverage
Terms and data sources used on this page
PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.
AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.
ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.
pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.
FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.
Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.
PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.
ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.
ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.
LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.
Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.
DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.
Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.
EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.
KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.
Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.
Prioritization evidence
Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.
Off-target risk
- Human off-target
- No hit
- Gut microbiome similarity
- 7.4% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.
Essentiality
- Essential (DEG)
- Y
- DEG identity (%)
- 93.671 Higher values support similarity to known essential genes.
- DEG E-value
- 0.0 Smaller values mean stronger essential-gene similarity.
Structure confidence
- ColabFold pLDDT
- 97.25 0-100 confidence; >70 supports local structural interpretation.
Binding-site evidence
AlphaFold DB / UniProt modelP2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
MQILLANPRGFCAGVDRAISIVENALTLYGAPIYVRHEVVHNRYVVDSLRKRGAIFIEQISEVPDGAILIFSAHGVSQAVRNEAKSRDLTVFDATCPLVTKVHMEVARASRRGEESILIGHAGHPEVEGTMGQYNNPQGGMYLVESPEDVLKLEVKNDARLSFMTQTTLSVDDTSDVIDALRARFPKIVGPRKDDICYATTNRQEAVRALAEQADVVLVVGSKNSSNSNRLAELAQRMGKAAYLIDDASDIQEAWVKDAACVGVTAGASAPDILVQNVITRLQELGGGEAVPLEGREENIVFEVPKELRVDVREVE
Functional annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Subcellular localization
- Localization
- Cytoplasmic
Enzyme Commission (EC)
1Gene Ontology (GO)
7- GO:0051745 Catalyzes the conversion of (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate + 2 H+ + 2 reduced [2Fe-2S]-[ferredoxin] to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) releasing H2O + 2 oxidized [2Fe-2S]-[ferredoxin]. Note that (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate is an alternative name for 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate.
- GO:0050992 The chemical reactions and pathways resulting in the formation of dimethylallyl diphosphate.
- GO:0019288 The chemical reactions and pathways resulting in the formation of isopentenyl diphosphate by the mevalonate-independent pathway. Isopentenyl diphosphate (IPP) is the fundamental unit in isoprenoid biosynthesis and is biosynthesized from pyruvate and glyceraldehyde 3-phosphate via intermediates, including 1-deoxy-D-xylulose 5-phosphate.
- GO:0046872 Binding to a metal ion.
- GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
- GO:0051539 Binding to a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
- GO:0016114 The chemical reactions and pathways resulting in the formation of terpenoids, any member of a class of compounds characterized by an isoprenoid chemical structure.
Sequence domains and features
Domain and signature matches imported from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 12 | 96 | FunFam | G3DSA:3.40.50.11270:FF:000001 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 1 | 314 | PANTHER | PTHR30426 | 4-HYDROXY-3-METHYLBUT-2-ENYL DIPHOSPHATE REDUCTASE |
| 1 | 314 | InterPro | IPR003451 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 2 | 284 | NCBIfam | TIGR00216 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 2 | 284 | InterPro | IPR003451 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 1 | 286 | Hamap | MF_00191 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase [ispH]. |
| 1 | 286 | InterPro | IPR003451 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 97 | 196 | Gene3D | G3DSA:3.40.1010.20 | - |
| 12 | 96 | Gene3D | G3DSA:3.40.50.11270 | - |
| 3 | 282 | CDD | cd13944 | lytB_ispH |
| 3 | 282 | InterPro | IPR003451 | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase |
| 3 | 282 | Pfam | PF02401 | LytB protein |
| 5 | 281 | Gene3D | G3DSA:3.40.1010.20 | - |
3D structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.
How colors and pocket overlays are used
Pocket details Inspect a specific pocket, or open the full viewer
- Method
- -
- Score
- -
- Visible layer
- -
- Residues
- -
- Pocket properties
- -
Selecting a pocket opens its details and centers the viewer without clearing other active layers. Use Focus this pocket when you want to hide the rest; use Surface for the wider residue environment.
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · FPocket
Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Residue sets
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · FPocket
Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Residue sets
All structural evidence
Structural evidence
0 + 2Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold DB
AF_A0A0H3GN13
|
AlphaFold DB | — | — | full sequence | — | Viewing |
|
ColabFold
VK055_2551
|
ColabFold | — | — | full sequence | — | Loaded |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Structural and bioactivity evidence are both available for this target.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in Target, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| 0CG RCSB PDB | P62623 | 216.0 Da LogP -0.15 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
C#CCOP(=O)(O)OP(=O)(O)O
|
|
| 0CH RCSB PDB | P62623 | 250.1 Da LogP -0.01 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C(CCOP(=O)(O)OP(=O)(O)O)CO
|
|
| 0CJ RCSB PDB | P62623 | 262.1 Da LogP 0.58 TPSA 130.4 | ✓ Ro5 | ✓ Clean |
CC(=O)CCCOP(=O)(O)OP(=O)(O)O
|
|
| 0CM RCSB PDB | P62623 | 230.0 Da LogP 0.24 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC#CCOP(=O)(O)OP(=O)(O)O
|
|
| 0CN RCSB PDB | P62623 | 230.0 Da LogP 0.55 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
C=C=CCOP(=O)(O)OP(=O)(O)O
|
|
| 0JX RCSB PDB | P62623 | 248.1 Da LogP 0.67 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C(COP(=O)(O)OP(=O)(O)O)/C=C/O
|
|
| 0K2 RCSB PDB | P62623 | 248.1 Da LogP 0.19 TPSA 130.4 | ✓ Ro5 | ✓ Clean |
C(CC=O)COP(=O)(O)OP(=O)(O)O
|
|
| 0O3 RCSB PDB | P62623 | 262.1 Da LogP 0.15 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C=C(CCOP(=O)(O)OP(=O)(O)O)CO
|
|
| 10D RCSB PDB | P62623 | 264.1 Da LogP 1.13 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
C/C(=C\COP(=O)(O)OP(=O)(O)O)/CF
|
|
| 10E RCSB PDB | P62623 | 261.1 Da LogP 0.12 TPSA 139.3 | ✓ Ro5 | ✓ Clean |
C/C(=C\COP(=O)(O)OP(=O)(O)O)/CN
|
|
| 10G RCSB PDB | P62623 | 278.2 Da LogP 1.09 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
C/C(=C\COP(=O)(O)OP(=O)(O)O)/CS
|
|
| DMA RCSB PDB | P62623 | 246.1 Da LogP 1.18 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(=CCO[P@@](=O)(O)OP(=O)(O)O)C
|
|
| EIP RCSB PDB | P62623 | 264.1 Da LogP 0.23 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C[C@@H](CCO[P@](=O)(O)OP(=O)(O)O)CO
|
|
| F3S RCSB PDB | P62623 | 295.8 Da LogP 2.59 TPSA 0.0 | ✓ Ro5 | ✓ Clean |
S1[Fe]2S[Fe]3[S]2[Fe]1S3
|
|
| H6P RCSB PDB | P62623 | 262.1 Da LogP 0.15 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C/C(=C\CO[P@@](=O)(O)OP(=O)(O)O)/CO
|
|
| IPE RCSB PDB | P62623 | 246.1 Da LogP 1.18 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
|
|
| POP RCSB PDB | P62623 | 176.0 Da LogP -2.08 TPSA 129.9 | ✓ Ro5 | ✓ Clean |
O[P@@](=O)([O-])O[P@@](=O)(O)[O-]
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC8215654 ZINC | 1.000 | 246.1 Da LogP 1.18 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
C=C(C)CCO[P@@](=O)(O)OP(=O)(O)O
|
| ZINC8215740 ZINC | 1.000 | 246.1 Da LogP 1.18 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
|
| ZINC8436838 ZINC | 1.000 | 262.1 Da LogP 0.15 TPSA 133.5 | ✓ Ro5 | ✓ Clean |
C/C(=C\CO[P@@](=O)(O)OP(=O)(O)O)CO
|
| ZINC71769106 ZINC | 0.923 | 326.1 Da LogP 1.30 TPSA 159.8 | ✓ Ro5 | ✓ Clean |
CC(C)=CCO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O
|
| ZINC8215849 ZINC | 0.719 | 314.2 Da LogP 2.91 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
|
| ZINC2579357 ZINC | 0.700 | 248.1 Da LogP 1.26 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)CCO[P@](=O)(O)OP(=O)(O)O
|
| ZINC12494625 ZINC | 0.697 | 382.3 Da LogP 4.63 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C/CC/C(C)=C/CO[P@@](=O)(O)OP(=O)…
|
| ZINC2356589248 ZINC | 0.697 | 382.3 Da LogP 4.63 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)=CCCC(C)=CCCC(C)=CCO[P@](=O)(O)OP(=O)(O)O
|
| ZINC34661063 ZINC | 0.676 | 394.2 Da LogP 3.02 TPSA 159.8 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)O[P@@](=O)(O)OP(…
|
| ZINC8218174 ZINC | 0.657 | 462.3 Da LogP 4.75 TPSA 159.8 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C/CC/C(C)=C/CO[P@@](=O)(O)O[P@@]…
|
| ZINC34020319 ZINC | 0.588 | 260.1 Da LogP 0.61 TPSA 124.3 | ✓ Ro5 | ✓ Clean |
C/C(=C\CC[P@@](=O)(O)OP(=O)(O)O)CO
|
| ZINC13539354 ZINC | 0.571 | 332.2 Da LogP 3.20 TPSA 113.3 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C(\F)CO[P@](=O)(O)OP(=O)(O)O
|
| ZINC39419974 ZINC | 0.520 | 212.1 Da LogP 1.04 TPSA 44.8 | ✓ Ro5 | ✓ Clean |
C#CCOP(=O)(OCC#C)OCC#C
|
| ZINC1532829 ZINC | 0.500 | 234.2 Da LogP 2.79 TPSA 66.8 | ✓ Ro5 | ✓ Clean |
CC(C)=CCC/C(C)=C/COP(=O)(O)O
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.
Cross-references
External database identifiers for this protein, its structures, ligands, and metabolic reactions.